What’s Driving Growth in the Predictive And Presymptomatic Testing Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Growth Rate of the Predictive And Presymptomatic Testing Market Shape Industry Trends by 2034?
The market size for predictive and presymptomatic testing has experienced swift expansion in recent times. The market will escalate from a value of $5.24 billion in 2024 up to $5.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. Factors contributing to growth during the historic period include a rise in genetic disorders, an increased desire for early chronic disease diagnosis, escalating cancer rates, enhanced use of personalized medicine, and an increase in readily available direct-to-consumer genetic tests.
Significant growth is forecasted for the predictive and presymptomatic testing market in the upcoming years, expecting to surge to $8.47 billion in 2029, with a compound annual growth rate (CAGR) of 10.1%. The amplified growth during this period can be associated with the escalating demand for early identification of diseases, the rise in biotech and genomics investments, a growing demand for non-invasive test methods, an increasing elderly population, and the expansion in precision medicine initiatives. Key trends anticipated during this time comprise the incorporation of individualized medicine, the use of home testing kits, the merger of genomics and large data, the emergence of next generation sequencing (NGS) technologies as well as the introduction of predictive testing within drug development.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Predictive And Presymptomatic Testing Market?
The predictive and presymptomatic testing market is anticipated to witness significant growth, driven by the increasing incidents of genetic disorders. Genetic disorders, such as cystic fibrosis and down syndrome, are caused by abnormalities in the DNA, which include gene mutations and alterations in the chromosomes. The surge in cases of genetic disorders can be attributed to causes such as advanced maternal age, environmental influences, and enhanced diagnostic methods. Predictive and presymptomatic testing aids in lessening the prevalence of these disorders by identifying those at risk prior to the onset of symptoms. By doing so, early interventions and modifications in lifestyle can be introduced that can help in preventing or lessening the severity of these disorders. For instance, as reported by the American Society of Gene and Cell Therapy, a non-profit medical and scientific organization based in the US, the number of gene therapies in Phase III clinical trials witnessed a quarterly growth of 10% in quarter 3, 2023, a first since quarter 3, 2022. Consequently, the escalating prevalence of genetic disorders is escalating the demand in the predictive and presymptomatic testing market.
Explore Comprehensive Insights Into The Global Predictive And Presymptomatic Testing Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20594&type=smp
Who Are the Key Market Players Influencing the Growth of the Predictive And Presymptomatic Testing Industry?
Major companies operating in the predictive and presymptomatic testing market are:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Mayo Clinic
• Quest Diagnostics Inc.
• Illumina Inc.
What Key Market Trends Are Shaping the Future of the Predictive And Presymptomatic Testing Industry?
Leading companies in the predictive and presymptomatic testing market are producing groundbreaking tests such as multigene testing. This type of testing allows the simultaneous analysis of many genes to detect possible health risks and make way for prompt interventions. What multigene testing really entails is a diagnostic technique that scrutinizes several genes at the same time to find genetic changes or variations potentially linked with certain diseases or conditions, thus helping in customised medicine and focused treatment approaches. For example, Genetic Technologies Limited, a biotech research firm located in Australia, collaborated with Siles Health, a women’s healthcare centre in Australia, in July 2022. They launched the geneType Multi-Risk Test, a tool designed to offer broad risk assessments for patients. The geneType Multi-Risk Test is an exhaustive genetic evaluation tool that gauges a patient’s risk for numerous severe diseases like breast cancer, colorectal cancer, and type 2 diabetes. The test seeks to enable early interventions and guide personalized healthcare strategies by examining both inherited and random genetic factors.
Get Instant Access to the Global Predictive And Presymptomatic Testing Market Report with Swift Delivery!
What Are the Main Segments of the Predictive And Presymptomatic Testing Market, and How Are They Evolving?
The predictive and presymptomatic testing market covered in this report is segmented –
1) By Test Type: Predictive Testing, Presymptomatic Testing
2) By Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Other Applications
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Predictive Testing: Genetic Testing for Inherited Conditions, Cancer Risk Prediction, Cardiovascular Disease Prediction, Neurodegenerative Disease Risk Prediction, Genetic Screening for Autosomal Dominant Disorders, Prenatal Predictive Testing, Pharmacogenomic Testing
2) By Presymptomatic Testing: Huntington’s Disease Testing, Hereditary Cancer Risk Testing, Cystic Fibrosis Presymptomatic Testing, Early-Onset Alzheimer’s Disease Testing, Carrier Screening for Genetic Conditions, Testing for Early Signs of Neurodegenerative Diseases, Presymptomatic Genetic Testing for Familial Diseases
Which Regions Are Emerging as Leaders in the Predictive And Presymptomatic Testing Market?
North America was the largest region in the predictive and presymptomatic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive and presymptomatic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Features of the Predictive And Presymptomatic Testing Market?
Predictive and presymptomatic testing are genetic tests designed to assess an individual’s risk of developing a disease before any symptoms arise, particularly for inherited conditions. These tests help identify people at increased risk for specific genetic disorders, enabling early intervention and personalized care. The benefits include early diagnosis, tailored prevention, and informed lifestyle choices.
Browse Through More Similar Reports By The Business Research Company:
Predictive Vehicle Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/predictive-vehicle-technology-global-market-report
Predictive Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/predictive-analytics-global-market-report
Predictive Maintenance Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/predictive-maintenance-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
